The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Show other versions (2)
Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Awduron Eraill: Richardson, Paul G. (Siaradwr)
Fformat: Electronig Fideo
Iaith:English
Cyhoeddwyd: London : Henry Stewart Talks, 2019.
Cyfres:Henry Stewart talks. Biomedical & life sciences collection.
Pynciau:
Antibody-drug conjugates.
Antineoplastic agents.
Multiple myeloma > Chemotherapy.
Multiple myeloma > Treatment.
Antibodies, Monoclonal > therapeutic use.
Antineoplastic Agents > therapeutic use.
Bortezomib.
Cancer Vaccines.
Drug Discovery.
elotuzumab.
Immunoconjugates > therapeutic use.
Immunotherapy > trends.
isatuximab.
Multiple Myeloma > drug therapy.
Multiple Myeloma > immunology.
Multiple Myeloma > therapy.
Receptors, Antigen, T-Cell > therapeutic use.
Recurrence.
T-Lymphocytes > immunology.
Mynediad Ar-lein:https://hstalks.com/bs/3990/
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

https://hstalks.com/bs/3990/

Eitemau Tebyg